Procter & Gamble Prices €3.25 Billion Bond Issue in Four Tranches Through 2046
Key Facts
Procter & Gamble priced €3.25 billion in euro-denominated senior notes across four tranches on October 27, 2026, according to Dealroom data. The issue is scheduled to settle on November 3, with maturities ranging from 2030 to 2046. Dealroom described the transaction as one of the largest post-IPO debt deals in the U.S. health and beauty sector, not as one of the company’s largest euro issues. The deal also ranked in the 98th percentile among 51 comparable transactions in the sector. The tranche structure gives investors multiple maturities through which to gain exposure to the company’s debt, while the company did not specify a particular use of proceeds in its filing with the Securities and Exchange Commission.
The tranche due in 2030 is about €750 million, followed by a €1 billion tranche due in 2034. The 2038 and 2046 tranches are each valued at €750 million, bringing the four-tranche total to €3.25 billion. The maturity schedule therefore runs from the earliest maturity in 2030 to the latest in 2046. Annual coupons range from 3.750% to 4.625%, according to Dealroom data. These coupons set the contractual interest cost for each tranche, while the principal repayment date varies according to its maturity.
All four tranches received ratings of Aa3 from Moody’s and AA- from S&P, according to Dealroom. The platform said the company intends to apply to list the bonds on the New York Stock Exchange. The joint bookrunners include Citigroup, Deutsche Bank, Goldman Sachs, HSBC and Morgan Stanley. That places the transaction within a multi-tranche financing managed by a group of five banks, with a uniform rating across all four tranches, according to the source. The company’s filing with the Securities and Exchange Commission did not state a specific purpose for the euro issue’s proceeds, so the available information does not link the offering to a particular project or announced use.
Procter & Gamble’s total debt stood at $38.925 billion on September 30, 2026, according to the company’s filing with the Securities and Exchange Commission. That figure excludes the euro notes on offer and the dollar issue the company expected to launch on October 30 for $4 billion. The company said in the filing that the euro offering is not conditional on completion of the dollar issue, and that neither offering’s completion depends on the other. The two issues were therefore separate in their arrangements, despite their close timing. The debt data thus provide a snapshot of outstanding obligations at the end of September before either of the two issues is accounted for.
The offering came as the company reported net sales of $23.276 billion for the quarter ended September 30, 2026, compared with $22.386 billion in the same period of 2025, an annual increase of 4%, according to its filing with the commission. Organic sales were $23.3 billion, also up 4%. These figures place first-quarter fiscal 2027 performance in the context of the bond issue, with sales growing year over year. The company’s shares, listed under ticker PG, closed at $159.23 on October 27, according to EL7 data. That is the closing price recorded for that day; the available information does not include the stock’s high or low.